EUVIMEDEUVIMED entdecken
Open Access

Progress in Immunization Safety Monitoring — Worldwide, 2020–2022

Erin F Blau, Madhava Ram Balakrishnan, Helena Sköld, Ravi Shankar Santhana Gopala Krishnan, Pinelopi Lundquist, Shanthi Pal, Jane F Gidudu

MMWR. Morbidity and Mortality Weekly Report · 08.12.2023 · 72 (49) · 1321-1326

DOI: 10.15585/mmwr.mm7249a2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, online erschienen am 08.12.2023. Verfasst von Erin F Blau und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Vaccines. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effective surveillance of adverse events following immunization (AEFIs) primarily relies on the collaboration of two partners: national regulatory authorities (NRAs) and national expanded programs on immunization (EPIs). In December 2020, the World Health Organization (WHO) Global Advisory Committee for Vaccine Safety recommended a new case-based indicator of national capacity to monitor immunization safety: at least one serious AEFI reported per 1 million total population per year. To achieve this indicator, WHO-affiliated countries and territories (WHO countries) rely upon data generated from functional AEFI surveillance systems. This report describes 2020-2022 global, regional, and national progress in use of the newly introduced immunization safety monitoring indicator and progress on joint AEFI reporting from national EPIs and NRAs. Among WHO countries, 51 (24%) of 214 implemented the new indicator in 2020, 111 (52%) of 214 implemented it in 2021, and 92 (43%) of 215 in 2022. In 2020, 41 (19%) WHO countries reported AEFI data jointly from EPIs and NRAs; this increased to 55 (26%) in 2021 and 57 (27%) in 2022. These findings, resulting in part from the intensified support for COVID-19 vaccination, demonstrate that national AEFI surveillance systems increasingly support the timely use and sharing of case-based immunization safety data, but work is still needed to strengthen global vaccine safety monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesVaccinesHumansAdverse Drug Reaction Reporting SystemsImmunizationVaccination

Substanzen

COVID-19 VaccinesVaccines

Zitieren

APA

Blau, E. F., Balakrishnan, M. R., Sköld, H., Santhana Gopala Krishnan, R. S., Lundquist, P., Pal, S., & Gidudu, J. F. (2023). Progress in Immunization Safety Monitoring — Worldwide, 2020–2022. MMWR. Morbidity and Mortality Weekly Report, 72(49), 1321-1326. https://doi.org/10.15585/mmwr.mm7249a2

Vancouver

Blau EF, Balakrishnan MR, Sköld H, Santhana Gopala Krishnan RS, Lundquist P, Pal S, et al. Progress in Immunization Safety Monitoring — Worldwide, 2020–2022. MMWR. Morbidity and Mortality Weekly Report. 2023;72(49):1321-1326. doi:10.15585/mmwr.mm7249a2

BibTeX
@article{Blau2023,
  author = {Blau, Erin F and Balakrishnan, Madhava Ram and Sköld, Helena and Santhana Gopala Krishnan, Ravi Shankar and Lundquist, Pinelopi and Pal, Shanthi and Gidudu, Jane F},
  title = {Progress in Immunization Safety Monitoring — Worldwide, 2020–2022},
  journal = {MMWR. Morbidity and Mortality Weekly Report},
  year = {2023},
  volume = {72},
  number = {49},
  pages = {1321--1326},
  doi = {10.15585/mmwr.mm7249a2}
}
Kostenlos starten →